U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06873360) titled 'Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients' on Feb. 15.
Brief Summary: This is an observational study related to a medical device designed for the prevention of oxaliplatin-induced peripheral neuropathy (OIPN) in patients with gastrointestinal cancer. The primary objective is to collect data through interviews with patients experiencing OIPN symptoms to co-design the medical device prototype, incorporating the patient's perspective. Additionally, the study aims to identify clinical and usability patterns that will help optimize the design of a future clinical investigation assessing the sa...